Title(s):
NRG-LU007 RAndomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR trial (NCT # NCT04402788)
Investigator(s): Praveen Pendyala, MD
Contact Information: McDowell Cancer Research 330.344.6348
Title(s):
NRG-LU008 Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer, (NCT05624996)
Investigator(s): Praveen Pendyala, MD
Contact Information: McDowell Cancer Research 330.344.6348
Title(s):
S2302 PRAGMATICA – LUNG: A Prospective Randomized Study of Ramucirumab (LY3009806; NSC 749128) plus Pembrolizumab (MK-3475; NSC 776864) versus Standard of Care for Participants Previously Treated with Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer
Investigator(s): Judy Tsai, MD
Contact Information: McDowell Cancer Research 330.344.6348
Title(s): CTSU A151216. Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Investigator(s): Esther Rehmus, MD
Contact Information: McDowell Cancer Research at 330.344.6348
Title(s): CTSU E4512. A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Investigator(s): Esther Rehmus, MD
Contact Information: McDowell Cancer Research at 330.344.6348
Title(s): S1827 MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
Investigator(s): Mitchel Fromm, MD
Contact Information: McDowell Cancer Research at 330.344.6348
Title(s): A081801 Integration of immunotherapy into adjuvant therapy for resected NSCLC: ALCHEMIST chemo-IO
Investigator(s): Esther Rehmus, MD
Contact Information: McDowell Cancer Research at 330.344.6348
